We are dedicated to creating thought-leading forums to share and connect. Watch one of our webcasts to gain insights on the industry’s hottest topics.

March 2023
Beyond the Script: Brighter Together
November 2022
2022 Virtual Reality
October 2022
Complying with the Consolidated Appropriations Act Section 204
September 2022
Analytics and Insights Driving Outcomes
March 2022
Psychedelics Meet Mainstream Medicine
November 2021
A Focus on Alzheimer's Treatment

** See note  about FDA Accelerated Approval at the bottom of this page.

September 2021
COVID-19 Booster News
September 2021
Taking action to prevent suicide
July 21, 2021
Children and the COVID-19 Vaccine
March 2, 2021
COVID-19: The Road to Immunity
February 2021
Take it to Heart
December 2020
Emotional Wellness during COVID-19 & the Holidays
October 2020
2020 Medicaid Trends
April 2020
Medical Pharmacy Trend Report Webcast
February 2020
Cracking Peanut Allergies
December 2019
Optimizing Health Outcomes Through Member Engagement
November 2019
Clinical Connections: Diabetes & Oral Semaglutide
September 2019
2019 Magellan Rx Management Medicaid Trend Report Webinar
August 2019
Clinical Connections: A Journey Through Zolgensma
April 2019
Medical Pharmacy Trends & Forecasting: Oncology
April 4, 2019
Clinical Connections: Precision Medicine in Oncology
March 2019
2018 Medical Pharmacy Trend Report
January 8, 2019
Clinical Connections: Hemlibra & Hemophilia
December 12, 2018
MRx Cares
October 15, 2018
MRx Predict: Identifying Tomorrow's Challenges Today
October 2, 2018
2018 Medicaid Pharmacy Trend Report
August 27, 2018
Live Vibrantly: Diabetes Management
August 14, 2018
Uncover What is Driving Pharmacy Spending
May 7, 2018
Our Approach to the Opioid Epidemic
April 17, 2018
Digital Therapeutics – the Future of Healthcare is Here
March 28, 2018
Magellan Method: Creating Partnerships That Transform Care
February 6, 2018
Clinical Strategies for Star Rating: Staying Ahead of a Moving Target
November 15, 2017
CAR-T: A New Clinical Frontier
October 25, 2017
MRx Pipeline - October 2017
September 27, 2017
Trends in the Medicaid Market
June 15, 2017
Medical Pharmacy Trend Report for Employers
May 3, 2017
MRx Pipeline - April 2017
December 1, 2016
Managing Specialty Spend

**Accelerated Approval is a type of FDA expedited review pathway. It allows for earlier approval of drugs that treat serious conditions, and that fill an unmet medical need based on a surrogate endpoint that is reasonably likely to predict clinical outcomes. A surrogate endpoint is a marker that is thought to predict clinical benefit, but is not itself a measure of clinical benefit. Subsequent confirmatory trials to confirm the clinical benefit must be conducted to support traditional full approval.